Chronic Diseases and Injuries in Canada
Volume 31 · Supplement 1 · Fall 2011
Patterns of Health Services Utilization in Rural Canada
Appendix 2. Provincial patterns by disease: detailed tables
Men | Women | |||||||
---|---|---|---|---|---|---|---|---|
Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | |
Circulatory Disease System (390-459)a | ||||||||
Ontario | 0.92 (0.92–0.92)* | 0.92 (0.92–0.92)* | 0.84 (0.84–0.85)* | 0.99 (0.97–1.00) | 1.01 (1.01–1.01)* | 0.97 (0.96–0.97)* | 0.93 (0.92–0.93)* | 0.83 (0.81–0.85)* |
Nova Scotia | 1.19 (1.17–1.21)* | 0.97 (0.96–0.98)* | 0.99 (0.98–1.00)* | 0.89 (0.85–0.93)* | 1.33 (1.31–1.35)* | 1.04 (1.03–1.05)* | 1.06 (1.05–1.07)* | 0.87 (0.83–0.91)* |
Coronary Heart Disease (410-414)a | ||||||||
British Columbia | 0.68 (0.65–0.71)* | 0.83 (0.81–0.85)* | 0.60 (0.59–0.62)* | 0.88 (0.82–0.93)* | 0.88 (0.83–0.92)* | 0.84 (0.82–0.87)* | 0.67 (0.65–0.70)* | 0.98 (0.91–1.06) |
Nova Scotia | 1.15 (1.09–1.20)* | 1.02 (0.99–1.04) | 1.01 (0.99–1.03) | 1.06 (0.94–1.19) | 1.46 (1.36–1.56)* | 1.13 (1.09–1.18)* | 1.02 (0.99–1.05) | 0.78 (0.64–0.95)* |
Stroke (430-434) a | ||||||||
British Columbia | 0.74 (0.61–0.89)* | 0.80 (0.72–0.89)* | 0.60 (0.53–0.67)* | 1.34 (1.08–1.66)* | 0.96 (0.80–1.15) | 0.78 (0.69–0.88)* | 0.58 (0.51–0.66)* | 1.75 (1.42–2.17)* |
Nova Scotia | 0.88 (0.57–1.38) | 1.20 (0.98–1.46) | 1.07 (0.92–1.25) | 0.51 (0.14–1.94) | 1.78 (1.17–2.70)* | 1.68 (1.35–2.09)* | 1.43 (1.20–1.71)* | 1.17 (0.40–3.39) |
Data sources: Nova Scotia Physician Claims Files, 2001–2002; Ontario Physician Claims Files, 2001–2002; British Columbia Medical Services Plan, 2000–2001. Abbreviations: CA, Census Agglomeration; CMA, Census Metropolitan Area; ICD-9, International Statistical Classification of Diseases and Related Health Problems, 9th Revision; MIZ, Metropolitan Influenced Area. a ICD-9 diagnostic codes. * Statistically significant at p < .05; reference group is CMA/CA = 1.00. |
Province | Sex | Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ |
---|---|---|---|---|---|
Ontario | Men | 1.15 (1.10–1.20)* | 1.28 (1.25–1.32)* | 1.58 (1.54–1.61)* | 2.10 (1.95–2.25)* |
Women | 1.27 (1.23–1.31)* | 1.48 (1.43–1.53)* | 1.91 (1.83–2.00)* | 2.10 (1.90–2.31)* | |
Nova Scotia | Men | 1.88 (1.71–2.06)* | 1.33 (1.24–1.42)* | 1.19 (1.13–1.26)* | 3.38 (2.83–4.02)* |
Women | 2.38 (2.12–2.68)* | 1.88 (1.73–2.03)* | 1.46 (1.36–1.56)* | 5.79 (4.86–6.90)* | |
British Columbia | Men | 1.01 (0.92–1.10) | 1.02 (0.96–1.07) | 1.29 (1.24–1.35)* | 1.82 (1.64–2.02)* |
Women | 1.39 (1.25–1.54)* | 1.29 (1.21–1.38)* | 1.70 (1.61–1.79)* | 2.37 (2.08–2.69)* | |
Data source: Hospital Morbidity Database, 2001–2002, Canadian Institute for Health Information. Abbreviations: CA, Census Agglomeration; CMA, Census Metropolitan Area; MIZ, Metropolitan Influenced Area. * Statistically significant at p < .05; reference group is CMA/CA = 1.00. |
Men | Women | |||||||
---|---|---|---|---|---|---|---|---|
Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | |
Cancers/neoplasms (140-239)a | ||||||||
Ontario | 0.95 (0.94–0.96)* | 0.99 (0.98–1.00)* | 0.91 (0.90–0.92)* | 0.98 (0.94–1.02) | 0.92 (0.92–0.93)* | 0.85 (0.84–0.86)* | 0.90 (0.88–0.91)* | 1.12 (1.08–1.16)* |
Nova Scotia | 1.09 (1.05–1.14)* | 0.94 (0.92–0.97)* | 0.83 (0.82–0.85)* | 1.01 (0.91–1.11) | 0.97 (0.93–1.02) | 0.97 (0.95–1.00)* | 0.79 (0.78–0.81)* | 0.76 (0.68–0.85)* |
Breast Cancer (174)a | ||||||||
British Columbia | N/A | N/A | N/A | N/A | 0.87 (0.79–0.95)* | 1.24 (1.19–1.31)* | 1.29 (1.24–1.35)* | 2.23 (2.03–2.44)* |
Nova Scotia | N/A | N/A | N/A | N/A | 0.81 (0.72–0.92)* | 0.87 (0.82–0.92)* | 0.82 (0.78–0.85)* | 0.55 (0.40–0.75)* |
Lung Cancer (162)a | ||||||||
British Columbia | 0.91 (0.78–1.07) | 1.28 (1.18–1.39)* | 1.23 (1.14–1.33)* | 1.67 (1.39–2.01)* | 0.89 (0.74–1.07) | 1.45 (1.33–1.58)* | 1.01 (0.92–1.11) | 2.81 (2.39–3.31)* |
Nova Scotia | 1.16 (0.97–1.40) | 0.97 (0.88–1.08) | 1.23 (1.15–1.32)* | 2.34 (1.75–3.14)* | 0.84 (0.65–1.09) | 0.95 (0.85–1.08) | 0.95 (0.87–1.04) | 0.36 (0.16–0.82)* |
Data sources: Nova Scotia Physician Claims Files, 2001–2002; Ontario Physician Claims Files, 2001–2002; British Columbia Medical Services Plan, 2000–2001. Abbreviations: CA, Census Agglomeration; CMA, Census Metropolitan Area; ICD-9, International Statistical Classification of Diseases and Related Health Problems, 9th Revision; MIZ, Metropolitan Influenced Area. a ICD-9 diagnostic codes. * Statistically significant at p < .05; reference group is CMA/CA = 1.00. |
Province | Sex | Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ |
---|---|---|---|---|---|
Ontario | Men | 1.00 (0.93–1.07) | 1.15 (1.09–1.20) * | 1.39 (1.35–1.45) * | 1.62 (1.43–1.85)* |
Women | 1.06 (1.02–1.10)* | 1.19 (1.14–1.24)* | 1.17 (1.10–1.24)* | 1.34 (1.16–1.54)* | |
Nova Scotia | Men | 1.72 (1.47–2.02)* | 1.30 (1.16–1.45)* | 1.12 (1.03–1.22)* | 4.49 (3.51–5.73)* |
Women | 1.69 (1.44–1.98)* | 1.44 (1.30–1.59)* | 1.24 (1.15–1.35)* | 2.85 (2.14–3.80)* | |
British Columbia | Men | 0.91 (0.78–1.06) | 1.01 (0.93–1.11) | 1.31 (1.21–1.41)* | 2.40 (2.06–2.79)* |
Women | 0.87 (0.75–1.00) | 0.88 (0.81–0.96)* | 1.11 (1.04–1.20)* | 1.53 (1.28–1.83)* | |
Data source: Hospital Morbidity Database, 2001–2002, Canadian Institute for Health Information. Abbreviations: CA, Census Agglomeration; CMA, Census Metropolitan Area; MIZ, Metropolitan Influenced Area. * Statistically significant at p < .05; reference group is CMA/CA = 1.00. |
Men | Women | |||||||
---|---|---|---|---|---|---|---|---|
Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | |
Respiratory System Disease (460-519)a | ||||||||
Ontario | 0.71 (0.70–0.71)* | 0.68 (0.67–0.68)* | 0.65 (0.65–0.66)* | 0.58 (0.57–0.59)* | 0.79 (0.79–0.79)* | 0.74 (0.74–0.75)* | 0.71 (0.71–0.72)* | 0.59 (0.58–0.60)* |
Nova Scotia | 1.15 (1.13–1.17)* | 1.01 (1.01–1.02)* | 0.94 (0.94–0.95)* | 0.96 (0.92–1.00)* | 1.17 (1.16–1.18)* | 1.05 (1.04–1.05)* | 0.96 (0.95–0.96)* | 0.97 (0.94–1.00)* |
Asthma (493)a | ||||||||
British Columbia | 0.63 (0.60–0.66)* | 0.82 (0.80–0.84)* | 0.64 (0.62–0.65)* | 0.75 (0.70–0.81)* | 0.70 (0.67–0.73)* | 0.94 (0.92–0.96)* | 0.69 (0.67–0.71)* | 0.97 (0.91–1.03) |
Ontario | 0.70 (0.69–0.71)* | 0.74 (0.73–0.75)* | 0.79 (0.78–0.81)* | 0.69 (0.34–0.74)* | 0.82 (0.81–0.83)* | 0.84 (0.83–0.85)* | 0.88 (0.86–0.90)* | 0.56 (0.51–0.60)* |
Nova Scotia | 1.05 (0.99–1.12) | 0.83 (0.81–0.86)* | 0.82 (0.80–0.84)* | 0.78 (0.66–0.92)* | 1.13 (1.07–1.19)* | 0.83 (0.81–0.86)* | 0.83 (0.81–0.85)* | 0.76 (0.66–0.88)* |
Chronic Obstructive Pulmonary Disease (490-492, 496)a | ||||||||
British Columbia | 0.77 (0.74–0.81)* | 0.87 (0.84–0.89)* | 0.90 (0.88–0.93)* | 1.21 (1.14–1.28)* | 0.78 (0.75–0.82)* | 0.93 (0.90–0.95)* | 0.96 (0.93–0.98)* | 1.33 (1.23–1.41)* |
Nova Scotia | 1.58 (1.50–1.66)* | 1.34 (1.30–1.37)* | 1.01 (0.98–1.03) | 1.22 (1.08–1.39)* | 1.19 (1.12–1.26)* | 1.34 (1.31–1.38)* | 1.03 (1.01–1.06)* | 1.35 (1.21–1.50)* |
Data sources: Nova Scotia Physician Claims Files, 2001–2002; Ontario Physician Claims Files, 2001–2002; British Columbia Medical Services Plan, 2000–2001. Abbreviations: CA, Census Agglomeration; CMA, Census Metropolitan Area; ICD-9, International Statistical Classification of Diseases and Related Health Problems, 9th Revision; MIZ, Metropolitan Influenced Area. a ICD-9 diagnostic codes. * Statistically significant at p < .05; reference group is CMA/CA = 1.00. |
Province | Sex | Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ |
---|---|---|---|---|---|
Ontario | Men | 1.20 (1.13–1.28)* | 1.45 (1.39–1.50)* | 1.72 (1.67–1.77)* | 2.32 (2.10–2.56)* |
Women | 1.21 (1.16–1.26)* | 1.49 (1.43–1.56)* | 1.88 (1.78–1.99)* | 2.97 (2.67–3.30)* | |
Nova Scotia | Men | 1.27 (1.09–1.48)* | 1.18 (1.08–1.30)* | 1.31 (1.22–1.40)* | 3.00 (2.35–3.82)* |
Women | 0.93 (0.76–1.13) | 1.08 (0.97–1.20) | 1.23 (1.14–1.33)* | 3.69 (2.91–4.68)* | |
British Columbia | Men | 0.88 (0.78–1.00)* | 0.96 (0.89–1.03) | 1.71 (1.62–1.81)* | 1.47 (1.26–1.72)* |
Women | 0.87 (0.74–1.01) | 1.02 (0.93–1.10) | 1.99 (1.88–2.11)* | 1.95 (1.65–2.30)* | |
Data source: Hospital Morbidity Database, 2001–2002, Canadian Institute for Health Information. Abbreviations: CA, Census Agglomeration; CMA, Census Metropolitan Area; MIZ, Metropolitan Influenced Area. * Statistically significant at p < .05; reference group is CMA/CA = 1.00. |
Men | Women | |||||||
---|---|---|---|---|---|---|---|---|
Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | |
Musculoskeletal System Disease (710-739)a | ||||||||
Ontario | 0.92 (0.91–0.92)* | 1.00 (0.99–1.00) | 0.98 (0.97–0.99)* | 0.95 (0.92–0.97)* | 0.91 (0.90–0.91) | 0.92 (0.91–0.92)* | 0.89 (0.89–0.90)* | 1.02 (1.00–1.04) |
Nova Scotia | 0.97 (0.95–0.99)* | 0.99 (0.98–1.00) | 0.89 (0.88–0.90)* | 0.87 (0.83–0.92)* | 1.05 (1.03–1.06)* | 1.03 (1.02–1.03)* | 0.88 (0.87–0.88)* | 0.93 (0.90–0.96)* |
Rheumatoid Arthritis (714)a | ||||||||
British Columbia | 1.09 (0.99–1.19) | 1.56 (1.49–1.64)* | 0.93 (0.88–0.98)* | 1.79 (1.60–2.00)* | 1.06 (1.00–1.13)* | 1.42 (1.38–1.46)* | 1.16 (1.13–1.20)* | 2.48 (2.33–2.63)* |
Nova Scotia | 1.38 (1.20–1.59)* | 1.11 (1.03–1.21)* | 0.89 (0.83–0.95)* | 0.60 (0.37–0.97)* | 1.10 (1.00–1.22) | 1.08 (1.03–1.14)* | 0.90 (0.87–0.94)* | 1.00 (0.79–1.25) |
Osteoarthritis (715)a | ||||||||
British Columbia | 0.73 (0.69–0.78)* | 1.06 (1.03–1.09)* | 0.80 (0.78–0.83)* | 1.20 (1.12–1.29)* | 0.83 (0.79–0.86)* | 1.09 (1.07–1.12)* | 0.81 (0.79–0.83)* | 1.31 (1.24–1.39)* |
Nova Scotia | 1.14 (1.05–1.23)* | 0.96 (0.92–1.00) | 0.84 (0.81–0.87)* | 1.00 (0.83–1.22) | 1.15 (1.07–1.23)* | 1.02 (0.98–1.06) | 0.94 (0.91–0.97)* | 0.99 (0.85–1.16) |
Rheumatoid Arthritis and Osteoarthritis combined (714-715)a | ||||||||
Ontario | 1.07 (1.06–1.09)* | 1.16 (1.15–1.18)* | 1.05 (1.03–1.07)* | 1.20 (1.14–1.27)* | 0.95 (0.94–0.95)* | 0.97 (0.96–0.99)* | 0.94 (0.92–0.95)* | 1.39 (1.33–1.44)* |
Data sources: Nova Scotia Physician Claims Files, 2001–2002; Ontario Physician Claims Files, 2001–2002; British Columbia Medical Services Plan, 2000–2001. Abbreviations: CA, Census Agglomeration; CMA, Census Metropolitan Area; ICD-9, International Statistical Classification of Diseases and Related Health Problems, 9th Revision; MIZ, Metropolitan Influenced Area. a ICD-9 diagnostic codes. * Statistically significant at p < .05; reference group is CMA/CA = 1.00. |
Province | Sex | Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ |
---|---|---|---|---|---|
Ontario | Men | 1.31 (1.20–1.42)* | 1.40 (1.33–1.48)* | 1.76 (1.69–1.84)* | 1.69 (1.42–2.00)* |
Women | 1.16 (1.10–1.22)* | 1.40 (1.33–1.48)* | 1.66 (1.55–1.78)* | 1.93 (1.65–2.26)* | |
Nova Scotia | Men | 1.32 (1.05–1.66)* | 1.16 (1.00–1.34)* | 0.98 (0.87–1.10) | 3.95 (2.83–5.52)* |
Women | 1.45 (1.14–1.83)* | 1.19 (1.03–1.39)* | 1.06 (0.94–1.20) | 5.35 (3.99–7.18)* | |
British Columbia | Men | 1.10 (0.93–1.30) | 1.35 (1.24–1.49)* | 1.54 (1.42–1.67)* | 1.71 (1.38–2.10)* |
Women | 1.13 (0.96–1.34) | 1.20 (1.09–1.32)* | 1.81 (1.68–1.96)* | 2.46 (2.04–2.97)* | |
Data source: Hospital Morbidity Database, 2001–2002, Canadian Institute for Health Information. Abbreviations: CA, Census Agglomeration; CMA, Census Metropolitan Area; MIZ, Metropolitan Influenced Area. * Statistically significant at p < .05; reference group is CMA/CA = 1.00. |
Men | Women | |||||||
---|---|---|---|---|---|---|---|---|
Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | |
Injuries and Poisonings (802-894, 977-998 and 959)a | ||||||||
Ontario | 0.98 (0.98–0.99)* | 1.10 (1.09–1.10)* | 1.15 (1.14–1.16)* | 1.17 (1.15–1.20)* | 0.94 (0.94–0.95)* | 1.01 (1.00–1.02)* | 1.06 (1.05–1.07)* | 1.23 (1.20–1.26)* |
Nova Scotia | 1.19 (1.16–1.23)* | 1.18 (1.16–1.19)* | 1.08 (1.06–1.09)* | 1.21 (1.14–1.28)* | 1.22 (1.19–1.25)* | 1.11 (1.09–1.12)* | 0.98 (0.97–0.99)* | 0.96 (0.90–1.03) |
Data sources: Nova Scotia Physician Claims Files, 2001–2002; Ontario Physician Claims Files, 2001–2002. Abbreviations: CA, Census Agglomeration; CMA, Census Metropolitan Area; ICD-9, International Statistical Classification of Diseases and Related Health Problems, 9th Revision; MIZ, Metropolitan Influenced Area. a ICD-9 diagnostic codes. * Statistically significant at p < .05; reference group is CMA/CA = 1.00. |
Province | Sex | Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ |
---|---|---|---|---|---|
Ontario | Men | 1.31 (1.24–1.39)* | 1.52 (1.46–1.58)* | 1.94 (1.88–2.00)* | 2.46 (2.22–2.73)* |
Women | 1.25 (1.20–1.30)* | 1.48 (1.41–1.54)* | 1.90 (1.80–2.00)* | 3.19 (2.88–3.53)* | |
Nova Scotia | Men | 1.15 (0.96–1.39) | 1.30 (1.17–1.44)* | 1.09 (1.00–1.19)* | 2.06 (1.46–2.91)* |
Women | 1.32 (1.08–1.62)* | 1.29 (1.14–1.45)* | 0.97 (0.88–1.08) | 2.01 (1.36–2.98)* | |
British Columbia | Men | 0.96 (0.86–1.07) | 1.34 (1.27–1.42)* | 1.96 (1.88–2.06)* | 1.90 (1.68–2.15)* |
Women | 1.01 (0.89–1.14) | 1.21 (1.13–1.30)* | 1.93 (1.83–2.04)* | 2.23 (1.94–2.56)* | |
Data source: Hospital Morbidity Database, 2001–2002, Canadian Institute for Health Information. * Statistically significant at p < .05; reference group is CMA/CA = 1.00. Abbreviations: CA, Census Agglomeration; CMA, Census Metropolitan Area; MIZ, Metropolitan Influenced Area. |
Men | Women | |||||||
---|---|---|---|---|---|---|---|---|
Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | |
Mental Disorders (290-319)a | ||||||||
Ontario | 0.64 (0.63–0.64)* | 0.65 (0.65–0.66)* | 0.60 (0.59–0.60)* | 0.54 (0.53–0.56)* | 0.74 (0.74–0.74)* | 0.70 (0.70–0.71)* | 0.69 (0.69–0.70)* | 0.50 (0.49–0.51)* |
Nova Scotia | 0.75 (0.73–0.78)* | 0.84 (0.83–0.85)* | 0.70 (0.69–0.71)* | 0.88 (0.82–0.94)* | 0.94 (0.92–0.95)* | 0.89 (0.88–0.90)* | 0.73 (0.72–0.74)* | 0.80 (0.76–0.84)* |
Depression (296.2, 296.3, 300.4, 311)a | ||||||||
British Columbia | 0.49 (0.48–0.51)* | 0.78 (0.77–0.79)* | 0.50 (0.49–0.51)* | 0.54 (0.51–0.56)* | 0.59 (0.58–0.60)* | 0.84 (0.83–0.85)* | 0.59 (0.58–0.59)* | 0.64 (0.62–0.66)* |
Nova Scotia | 0.80 (0.75–0.86)* | 0.72 (0.70–0.75)* | 0.69 (0.67–0.71)* | 0.69 (0.59–0.82)* | 0.96 (0.92–1.00) | 0.74 (0.73–0.76)* | 0.71 (0.70–0.72)* | 0.75 (0.68–0.82)* |
Data sources: Nova Scotia Physician Claims Files, 2001–2002; Ontario Physician Claims Files, 2001–2002; British Columbia Medical Services Plan, 2000–2001. Abbreviations: CA, Census Agglomeration; CMA, Census Metropolitan Area; ICD-9, International Statistical Classification of Diseases and Related Health Problems, 9th Revision; MIZ, Metropolitan Influenced Area. a ICD-9 diagnostic codes. * Statistically significant at p < .05; reference group is CMA/CA = 1.00. |
Province | Sex | Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ |
---|---|---|---|---|---|
Ontario | Men | 0.82 (0.75–0.90)* | 1.54 (1.46–1.61)* | 1.99 (1.92–2.07)* | 2.79 (2.47–3.15)* |
Women | 0.82 (0.78–0.87)* | 1.54 (1.46–1.61)* | 1.99 (1.88–2.12)* | 2.79 (2.46–3.16)* | |
Nova Scotia | Men | 0.84 (0.65–1.11) | 0.81 (0.68–0.96)* | 1.37 (1.23–1.53)* | 3.69 (2.58–5.29)* |
Women | 0.83 (0.62–1.11) | 0.83 (0.70–0.98)* | 1.24 (1.11–1.38)* | 7.56 (5.97–9.58)* | |
British Columbia | Men | 0.62 (0.52–0.73)* | 1.21 (1.12–1.30)* | 1.52 (1.42–1.62)* | 1.65 (1.40–1.94)* |
Women | 0.63 (0.53–0.74)* | 0.98 (0.91–1.07) | 1.69 (1.60–1.80)* | 1.76 (1.49–2.08)* | |
Data source: Hospital Morbidity Database, 2001–2002, Canadian Institute for Health Information. Abbreviations: CA, Census Agglomeration; CMA, Census Metropolitan Area; MIZ, Metropolitan Influenced Area. * Statistically significant at p < .05; reference group is CMA/CA = 1.00. |
Men | Women | |||||||
---|---|---|---|---|---|---|---|---|
Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | |
Nervous System Disease (320-389)a | ||||||||
Ontario | 0.83 (0.82–0.83)* | 0.83 (0.82–0.83)* | 0.78 (0.78–0.79)* | 0.78 (0.76–0.80)* | 0.87 (0.86–0.87)* | 0.84 (0.84–0.85)* | 0.84 (0.83–0.84)* | 0.87 (0.85–0.89)* |
Nova Scotia | 0.97 (0.95–0.99)* | 1.01 (1.00–1.03)* | 0.97 (0.96–0.97)* | 0.85 (0.80–0.89)* | 0.99 (0.97–1.01) | 1.06 (1.05–1.06)* | 0.97 (0.97–0.98)* | 0.92 (0.88–0.95)* |
Alzheimer's/dementia disorders (331)a | ||||||||
British Columbia | 0.47 (0.34–0.64)* | 1.43 (1.27–1.60)* | 0.77 (0.94–0.88)* | 0.73 (0.50–1.08) | 1.18 (1.02–1.37)* | 1.73 (1.61–1.87)* | 0.82 (0.74–0.91)* | 0.62 (0.45–0.86)* |
Nova Scotia | 0.83 (0.54–1.29) | 1.09 (0.90–1.33) | 0.74 (0.62–0.88)* | 2.11 (1.13–3.95)* | 1.08 (0.73–1.58) | 1.22 (1.02–1.46)* | 0.84 (0.72–0.98)* | 1.66 (0.86–3.18) |
Data sources: Nova Scotia Physician Claims Files, 2001–2002; Ontario Physician Claims Files, 2001–2002; British Columbia Medical Services Plan, 2000–2001. Abbreviations: CA, Census Agglomeration; CMA, Census Metropolitan Area; ICD-9, International Statistical Classification of Diseases and Related Health Problems, 9th Revision; MIZ, Metropolitan Influenced Area. a ICD-9 diagnostic codes. * Statistically significant at p < .05; reference group is CMA/CA = 1.00. |
Province | Sex | Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ |
---|---|---|---|---|---|
Ontario | Men | 1.03 (0.89–1.19) | 1.44 (1.32–1.57)* | 1.72 (1.61–1.84)* | 2.00 (1.56–2.56)* |
Women | 1.16 (1.06–1.26)* | 1.63 (1.49–1.77)* | 2.07 (1.86–2.31)* | 1.68 (1.25–2.25)* | |
Nova Scotia | Men | 1.61 (1.23–2.11)* | 1.21 (1.01–1.46)* | 1.07 (0.92–1.24) | 7.40 (5.38–10.2)* |
Women | 1.48 (1.09–2.00)* | 1.23 (1.02–1.49)* | 1.18 (1.02–1.37)* | 4.61 (3.05–6.97)* | |
British Columbia | Men | 0.78 (0.61–0.99)* | 1.03 (0.91–1.17) | 1.49 (1.34–1.65)* | 1.54 (1.17–2.02)* |
Women | 0.85 (0.66–1.11) | 1.01 (0.87–1.16) | 1.66 (1.49–1.85)* | 2.80 (2.21–3.56)* | |
Data source: Hospital Morbidity Database, 2001–2002, Canadian Institute for Health Information. Abbreviations: CA, Census Agglomeration; CMA, Census Metropolitan Area; MIZ, Metropolitan Influenced Area. * Statistically significant at p < .05; reference group is CMA/CA = 1.00. |
Men | Women | |||||||
---|---|---|---|---|---|---|---|---|
Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | Strong MIZ | Moderate MIZ | Weak MIZ | No MIZ | |
Diabetes (250)a | ||||||||
British Columbia | 0.63 (0.60–0.65)* | 0.74 (0.73–0.76)* | 0.72 (0.70–0.73)* | 1.18 (1.14–1.22)* | 0.73 (0.71–0.76)* | 0.76 (0.75–0.78)* | 0.84 (0.82–0.85)* | 1.35 (1.30–1.41)* |
Ontario | 0.86 (0.86–0.87)* | 0.86 (0.85–0.87)* | 0.93 (0.92–0.94)* | 1.57 (1.52–1.62)* | 0.93 (0.92–0.94)* | 1.00 (0.99–1.01) | 0.98 (0.97–1.00)* | 2.11 (2.05–2.17)* |
Nova Scotia | 1.31 (1.27–1.36)* | 0.91 (0.89–0.93)* | 0.89 (0.88–0.91)* | 1.21 (1.11–1.32)* | 1.35 (1.29–1.41)* | 1.08 (1.05–1.11)* | 1.01 (0.99–1.03) | 1.66 (1.53–1.79)* |
Data sources: Nova Scotia Physician Claims Files, 2001–2002; Ontario Physician Claims Files, 2001–2002; British Columbia Medical Services Plan, 2000–2001. Abbreviations: CA, Census Agglomeration; CMA, Census Metropolitan Area; ICD-9, International Statistical Classification of Diseases and Related Health Problems, 9th Revision; MIZ,Metropolitan Influenced Area. a ICD-9 diagnostic code. * Statistically significant at p < .05; reference group is CMA/CA = 1.00. |
Page details
- Date modified: